With regard to molecular subtypes, BC can be broadly classified into three groups: hormone receptor-positive (HR+) (expressing estrogen receptor (ER+) or progesterone receptor (PR+)), human epidermal growth factor receptor 2-positive (HER2+), or triple-negative breast cancer (TNBC) [10,11]. This evidence concerns the gene ERBB2 and breast cancer.